

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.


(Sharecast News) - Ondine Biomedical announced the launch of its phase three clinical trial for 'light-activated antimicrobial therapy to prevent surg...


(Sharecast News) - Ondine Biomedical announced the launch of its phase three clinical trial for 'light-activated antimicrobial therapy to prevent surg...


(Alliance News) - Ondine Biomedical Inc on Monday said it has recruited and treated the first patient in its phase 3 clinical trial evaluating its non...


(Sharecast News) - Ondine Biomedical announced on Tuesday that it would begin its phase three 'LANTERN' clinical trial for its novel nasal photodisinf...


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.


(Sharecast News) - Ondine Biomedical announced a proposed minimum £8.5m fundraising through a placing and subscription of new shares on Friday, p...


(Alliance News) - Ondine Biomedical Inc on Friday revealed a proposed fundraise as it looks to fund a phase 3 clinical study in the US.